Company
FluoGuide A/S
Headquarters: Copenhagen, Denmark
Employees: 3
Market Cap
kr678.8 Million
SEK as of Jan. 1, 2023
US$65.0 Million
Top Competitors by Market Capitalization
Industry: Medical Instruments & Supplies
| Company | Market Cap (USD) |
|---|---|
Intuitive Surgical, Inc.
|
$93.87 B |
EssilorLuxottica SA
|
$82.37 B |
|
Becton, Dickinson and Company
|
$72.82 B |
Alcon Inc.
|
$34.14 B |
HOYA Corp
|
$33.01 B |
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
|
UnitedHealth Group
|
$495.37 B |
|
Johnson & Johnson
|
$461.85 B |
|
Lilly
|
$347.61 B |
Novo Nordisk
|
$304.61 B |
|
Pfizer
|
$287.63 B |
Detailed Description
FluoGuide A/S, a life science company, engages in the development and sale of surgical solutions in Denmark. It develops FG001, which is in phase I/II for the treatment of high-grade glioma; and FG002 that allows surgeons to differentiate cancer from normal tissue during surgery through a novel urokinase-type plasminogen activator receptor targeted luminescent technology. It has an agreement with Linköping University Hospital for the development of FG001 that is in the phase I/II clinical trial for surgical removal of brain cancer; and a collaboration with Copenhagen University Hospital. The company was founded in 2018 and is based in Copenhagen, Denmark.